Company · CIK 1622229
Cogent Biosciences, Inc.
| CIK | 1622229 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | COGT (Nasdaq) |
| First annual or quarterly report | 2018-05-14 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291384 | 2025-11-07 | 2026-08-10 | 6 | |
| 333-269707 | 2023-02-10 | 2025-07-09 | 6 | |
| 333-264773 | 2022-05-06 | 2025-05-09 | 5 | |
| 333-278382 | 2024-03-29 | 2024-04-10 | 2 | |
| 333-252873 | 2021-02-09 | 2022-05-13 | 3 | |
| 333-230678 | 2019-04-02 | 2020-12-02 | 5 | |
| 333-248971 | 2020-09-22 | 2020-10-15 | 2 | |
| 333-223414 | 2018-03-02 | 2018-03-29 | 4 |
Filings
34| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-10 | 424B5Shelf takedown | 333-291384 | 0001193125-26-342683 |
| 2025-11-12 | 424B5Shelf takedown | 333-291384 | 0001193125-25-277586 |
| 2025-11-12 | 424B5Shelf takedown | 333-291384 | 0001193125-25-277503 |
| 2025-11-12 | 424B5Shelf takedown | 333-291384 | 0001193125-25-274642 |
| 2025-11-12 | 424B5Shelf takedown | 333-291384 | 0001193125-25-274621 |
| 2025-11-07 | S-3ASRShelf registered | 333-291384 | 0001193125-25-272499 |
| 2025-07-09 | 424B5Shelf takedown | 333-269707 | 0001193125-25-157121 |
| 2025-07-08 | 424B5Shelf takedown | 333-269707 | 0001193125-25-156654 |
| 2025-05-09 | EFFECTDeclared effective | 333-264773 | 9999999995-25-001478 |
| 2025-05-06 | 424B5Shelf takedown | 333-269707 | 0001193125-25-113402 |
| 2024-04-10 | EFFECTDeclared effective | 333-278382 | 9999999995-24-000926 |
| 2024-03-29 | S-3Shelf registered | 333-278382 | 0001193125-24-082065 |
| 2023-06-08 | 424B5Shelf takedown | 333-269707 | 0001193125-23-163485 |
| 2023-06-06 | 424B5Shelf takedown | 333-269707 | 0001193125-23-161747 |
| 2023-02-10 | S-3ASRShelf registered | 333-269707 | 0001193125-23-032798 |
| 2022-06-15 | 424B5Shelf takedown | 333-264773 | 0001193125-22-174881 |
| 2022-06-13 | 424B5Shelf takedown | 333-264773 | 0001193125-22-172369 |
| 2022-05-24 | EFFECTDeclared effective | 333-264773 | 9999999995-22-001579 |
| 2022-05-13 | EFFECTDeclared effective | 333-252873 | 9999999995-22-001452 |
| 2022-05-06 | S-3Shelf registered | 333-264773 | 0001193125-22-143829 |
| 2021-03-18 | EFFECTDeclared effective | 333-252873 | 9999999995-21-000998 |
| 2021-02-09 | S-3Shelf registered | 333-252873 | 0001193125-21-032929 |
| 2020-12-02 | 424B5Shelf takedown | 333-230678 | 0001193125-20-308495 |
| 2020-11-30 | 424B5Shelf takedown | 333-230678 | 0001193125-20-305790 |
| 2020-10-15 | EFFECTDeclared effective | 333-248971 | 9999999995-20-002858 |
| 2020-09-22 | S-3Shelf registered | 333-248971 | 0001193125-20-251424 |
| 2020-03-20 | 424B5Shelf takedown | 333-230678 | 0001193125-20-080016 |
| 2019-05-01 | EFFECTDeclared effective | 333-230678 | 9999999995-19-000978 |
| 2019-04-02 | S-3Shelf registered | 333-230678 | 0001193125-19-094845 |
| 2018-03-29 | 424B4Final prospectus | 333-223414 | 0001193125-18-102267 |
| 2018-03-28 | EFFECTDeclared effective | 333-223414 | 9999999995-18-000701 |
| 2018-03-19 | S-1/AAmendment | 333-223414 | 0001193125-18-086716 |
| 2018-03-02 | S-1Registration filed | 333-223414 | 0001193125-18-068918 |
| 2017-11-03 | DRSDraft made public | 377-01774 | 0000950123-17-009511 |